The sensitivity and specificity of SFRP2 methylation assay for CRC and precancerous lesions was 90.5% and 85.4%, respectively.

• 检测SFRP2基因甲基化诊断CRC及癌前病变的敏感性和特异性分别为90.；5%25和85